论文部分内容阅读
分析食管癌放疗后局部复发患者８０例，其中行再程放疗４０例（再放组），化疗４０例（化疗组）。结果：再放组与化疗组的进食改善率分别为８７．５％与２０．０％，Ｘ片示完全缓解（ＣＲ）加部分缓解（ＰＲ）前者为８０．０％，后者为２５．０％，比较有显著性差异（Ｐ＜０．０１）。再放组的１，２，３年生存率为３５．０％，１５．０％，５．０％，化疗组为７．５％，２．５％，０．０％，两组１年生存率比较有显著性差异（Ｐ＜０．０１）。结论：再程放疗可缓解患者症状，延长生存期。再程放疗的方法采用体外照射加腔内放疗
Analysis of 80 patients with local recurrence after radiotherapy for esophageal cancer, including 40 cases of re-radiotherapy (re-discharge group), 40 cases of chemotherapy (chemotherapy group). RESULTS: The feeding improvement rates of the re-administration group and the chemotherapy group were 87.5% and 20.0%, respectively, and the X-slices showed that the complete remission (CR) plus partial remission (PR) was 80.0% for the former and 25.0% for the latter. 0%, there was a significant difference (P <0.01). The 1-, 2-, and 3-year survival rates of the reintroduction group were 35.0%, 15.0%, and 5.0%, and 7.5%, 2.5%, and 0.0% in the chemotherapy group. The survival rate was significantly different (P<0.01). Conclusion: Re-radiotherapy can relieve symptoms and prolong survival. Re-radiotherapy using external irradiation and intra-cavity radiotherapy